The U.S. owns the lead in the critical categories of scientific quality and commercial know-how. However, Chinese development is faster, bigger and cheaper—and gaining on us. Which nation will ultimately prevail?
An alleged whistleblower working for Abbott, Kris Ghosh, claims to have evidence of Pacific Vascular Institute utilizing more products for atherectomy procedures than medically necessary.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
